In this episode we talk to Mark Lowdell, a professor of cell and tissue therapy at UCL. Mark is also co-founder and owner of INmuneBio and Autolomous, two business at the forefront of the burgeoning field of immuno-oncology, an exciting and hugely important area of medicine. Today we ask Mark about his leadership journey. We discuss how he fell into leadership, and how he is helping to establish new practices that are redefining the relationships between academic research and commercial big pharma.
Go to the INmuneBio’s website: https://www.inmunebio.com/index.php/en/
Go to the Autolomous’ website: https://www.autolomous.com/
Follow Coffee First on Twitter: coffeefirst13
Follow Amrop UK on LinkedIn: https://www.linkedin.com/company/amrop-uk/
Go to the Amrop UK’s website: https://www.amrop.co.uk/
Email Coffee First: coffeefirst@amrop.co.uk
Music featured: "Wonderflux - Visions" by Argofox, used under CC BY
Hosted by Adam Saunders
Research by Charlotte Price
Edited by Fabiana Ottini
Go to the INmuneBio’s website: https://www.inmunebio.com/index.php/en/
Go to the Autolomous’ website: https://www.autolomous.com/
Follow Coffee First on Twitter: coffeefirst13
Follow Amrop UK on LinkedIn: https://www.linkedin.com/company/amrop-uk/
Go to the Amrop UK’s website: https://www.amrop.co.uk/
Email Coffee First: coffeefirst@amrop.co.uk
Music featured: "Wonderflux - Visions" by Argofox, used under CC BY
Hosted by Adam Saunders
Research by Charlotte Price
Edited by Fabiana Ottini
The podcast Coffee First is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.